Subhankar Ray

829 total citations
29 papers, 714 citations indexed

About

Subhankar Ray is a scholar working on Molecular Biology, Clinical Biochemistry and Cancer Research. According to data from OpenAlex, Subhankar Ray has authored 29 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Clinical Biochemistry and 8 papers in Cancer Research. Recurrent topics in Subhankar Ray's work include Advanced Glycation End Products research (10 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Enzyme Structure and Function (6 papers). Subhankar Ray is often cited by papers focused on Advanced Glycation End Products research (10 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Enzyme Structure and Function (6 papers). Subhankar Ray collaborates with scholars based in India, Switzerland and United States. Subhankar Ray's co-authors include Manju Ray, Manabendra Ray, A. B. Banerjee, Krishna Misra, Swati Biswas, Soumen Bera, Bhabatosh Chaudhuri, Manju Ghosh, Sanjoy Das and Theo Wallimann and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and FEBS Letters.

In The Last Decade

Subhankar Ray

28 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subhankar Ray India 15 383 364 156 100 76 29 714
Ghislain Delpierre Belgium 15 467 1.2× 464 1.3× 151 1.0× 13 0.1× 84 1.1× 16 985
Koichi Ogawa Japan 13 258 0.7× 86 0.2× 96 0.6× 16 0.2× 81 1.1× 35 523
P. Sneha India 16 468 1.2× 44 0.1× 87 0.6× 21 0.2× 71 0.9× 30 763
R.P. McAndrew United States 15 458 1.2× 107 0.3× 55 0.4× 22 0.2× 27 0.4× 24 676
S. Ohmori Japan 12 179 0.5× 65 0.2× 77 0.5× 12 0.1× 34 0.4× 29 389
Malin Hult Sweden 10 506 1.3× 37 0.1× 49 0.3× 20 0.2× 148 1.9× 13 896
Paola Granata Italy 15 221 0.6× 16 0.0× 82 0.5× 54 0.5× 34 0.4× 33 1.2k
P.L. Sawant India 9 291 0.8× 44 0.1× 149 1.0× 21 0.2× 88 1.2× 22 609
Gerardo Suárez United States 5 173 0.5× 163 0.4× 48 0.3× 10 0.1× 28 0.4× 8 405
Vannuruswamy Garikapati Germany 12 241 0.6× 60 0.2× 31 0.2× 68 0.7× 26 0.3× 18 489

Countries citing papers authored by Subhankar Ray

Since Specialization
Citations

This map shows the geographic impact of Subhankar Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhankar Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhankar Ray more than expected).

Fields of papers citing papers by Subhankar Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhankar Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhankar Ray. The network helps show where Subhankar Ray may publish in the future.

Co-authorship network of co-authors of Subhankar Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Subhankar Ray. A scholar is included among the top collaborators of Subhankar Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhankar Ray. Subhankar Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Mahua, Arup K. Bag, Shekhar Saha, et al.. (2016). Molecular association of glucose-6-phosphate isomerase and pyruvate kinase M2 with glyceraldehyde-3-phosphate dehydrogenase in cancer cells. BMC Cancer. 16(1). 152–152. 19 indexed citations
2.
Ray, Manju, et al.. (2015). Nanofabrication of methylglyoxal with chitosan biopolymer: a potential tool for enhancement of its anticancer effect. International Journal of Nanomedicine. 10. 3499–3499. 14 indexed citations
3.
Ghosh, Alok, et al.. (2011). Methylglyoxal induces mitochondria-dependent apoptosis in sarcoma. Biochemistry (Moscow). 76(10). 1164–1171. 22 indexed citations
4.
Roy, Amrita, Soumen Bera, Subrata Patra, Subhankar Ray, & Manabendra Ray. (2009). A novel D‐glyceraldehyde‐3‐phosphate binding protein, a truncated albumin, with D‐glyceraldehyde‐3‐phosphate dehydrogenase inhibitory property. IUBMB Life. 61(10). 995–1000. 1 indexed citations
5.
Chaudhuri, Bhabatosh, et al.. (2009). Critical evaluation of toxic versus beneficial effects of methylglyoxal. Biochemistry (Moscow). 74(10). 1059–1069. 48 indexed citations
6.
Ray, Subhankar, et al.. (2008). A BRIEF CRITICAL OVERVIEW OF THE BIOLOGICAL EFFECTS OF METHYLGLYOXAL AND FURTHER EVALUATION OF A METHYLGLYOXAL-BASED ANTICANCER FORMULATION IN TREATING CANCER PATIENTS. Drug metabolism and drug interactions. 23(1-2). 175–210. 30 indexed citations
7.
Bera, Soumen, Theo Wallimann, Subhankar Ray, & Manju Ray. (2008). Enzymes of creatine biosynthesis, arginine and methionine metabolism in normal and malignant cells. FEBS Journal. 275(23). 5899–5909. 28 indexed citations
8.
Ghosh, Manju, et al.. (2005). In vivo assessment of toxicity and pharmacokinetics of methylglyoxal. Toxicology and Applied Pharmacology. 212(1). 45–58. 62 indexed citations
10.
Mukherjee, Kasturi, et al.. (2002). Purification and characterization of 3-phosphoglycerate kinase from Ehrlich ascites carcinoma cells.. PubMed. 39(5). 332–41. 1 indexed citations
11.
Ray, Manabendra, et al.. (2001). Identification of a critical lysine residue at the active site in glyceraldehyde‐3‐phosphate dehydrogenase of Ehrlich ascites carcinoma cell. European Journal of Biochemistry. 268(23). 6037–6044. 11 indexed citations
12.
Ray, Manabendra, et al.. (1999). Glyceraldehyde‐3‐phosphate dehydrogenase from Ehrlich ascites carcinoma cells. European Journal of Biochemistry. 262(2). 386–395. 16 indexed citations
14.
Ray, Subhankar, Swati Biswas, & Manabendra Ray. (1997). Similar nature of inhibition of mitochondrial respiration of heart tissue and malignant cells by methylglyoxal. A vital clue to understand the biochemical basis of malignancy. Molecular and Cellular Biochemistry. 171(1-2). 95–103. 17 indexed citations
15.
Banerjee, A. B., et al.. (1996). Reduction of methylglyoxal in Escherichia coli K12 by an aldehyde reductase and alcohol dehydrogenase. Molecular and Cellular Biochemistry. 156(2). 117–124. 41 indexed citations
16.
Pahan, Kalipada, et al.. (1993). Stimulatory effect of phenylmercuric acetate and benzene on the growth of a broad spectrum mercury‐resistant strain of Bacillus pasteurii. Journal of Applied Bacteriology. 74(3). 248–252. 5 indexed citations
17.
Ray, Manju & Subhankar Ray. (1987). Aminoacetone oxidase from goat liver. Formation of methylglyoxal from aminoacetone.. Journal of Biological Chemistry. 262(13). 5974–5977. 56 indexed citations
18.
Ray, Subhankar & Manju Ray. (1984). Oxidation of lactaldehyde by cytosolic aldehyde dehydrogenase and inhibition of cytosolic and mitochondrial aldehyde dehydrogenase by metabolites. Biochimica et Biophysica Acta (BBA) - General Subjects. 802(1). 128–134. 10 indexed citations
19.
Ray, Manju & Subhankar Ray. (1982). On the interaction of nucleotides and glycolytic intermediates with NAD-linked alpha-ketoaldehyde dehydrogenase.. Journal of Biological Chemistry. 257(18). 10571–10574. 10 indexed citations
20.
Ray, Subhankar & Manju Ray. (1981). Isolation of methylglyoxal synthase from goat liver.. Journal of Biological Chemistry. 256(12). 6230–6233. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026